Southwest Retina Research Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration4 trials
• Diabetic eye disease1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Completed2 trials
• Enrolling by invitation1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Gyroscope Therapeutics Limited2 trials
• Hoffmann-La Roche1 trial
• Novartis Pharmaceuticals1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Enrolling by invitation

  ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

  NCT05481827· Phase 2· Gyroscope Therapeutics Limited· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration2 recruiting

Closed trials

• Completed

  A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

  NCT05230537· Phase 2· Novartis Pharmaceuticals· Source

• Terminated

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· Phase 2· Gyroscope Therapeutics Limited· Source

• Completed

  A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

  NCT04503551· Phase 3· Hoffmann-La Roche· Source